UNLOCK AI-POWERED
Integrated GenAI Search
Drug Research, Clinical & Regulatory Data
Integrated GenAI Search
View More →ADC Drugs
Drugs
Companies
Clinical trials
Drug Price
Drug development
Regulatory Designation
Patent expiry
Sales forecast
Manufacturing
News
Deals
BioPharmaKSM
View More →12,000+ Drug manufactures
18,000+ Facilities
6,600+ Active ingredients
140+ service types
Global Coverage
360BioPharmaTracker
View More →LIVE News
30,000+ Drug Developments
4,500 Corporate Deals
3,500 Product Deals
6,000 Key Appointments
3,890 Sponsor Events since 2000
Clinical Trials Accelerators
View More →72%
Trial timelines increase clinical trial operational efficiency
Dynamic comparision against succesful trials
Recommends protocol modifications
Reduce clinical trial costs
Reformulation & Repurpose Platform
View More →Trained AI model on 10,000+ pipeline and approved drugs
Recommends drugs eligible for repurpose / reformulation based on scientific, commercial, and technology parameters
Dynamic model updates based on new drugs in to research and new drug approvals
HEOR Tracker
View More →Improvement in QALY based on economical treatment options
Drug Pricing: Refers to the structured data on how drugs are priced (list, net, negotiated) and the mechanisms by which payers, insurers, and health systems reimburse them.
HTA: A systematic evaluation of a drug's clinical effectiveness, cost-effectiveness, and broader impact on healthcare systems.
Therapy Cost: The total cost of treatment per patient or population, including drug acquisition, administration, monitoring, and supportive care.
IRP: A policy mechanism where a country sets or negotiates drug prices based on prices in other reference countries.